Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda

dc.contributor.authorKent, D. M.en
dc.contributor.authorMcGrath, D.en
dc.contributor.authorIoannidis, J. P.en
dc.contributor.authorBennish, M. L.en
dc.date.accessioned2015-11-24T18:49:45Z
dc.date.available2015-11-24T18:49:45Z
dc.identifier.issn1537-6591-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18000
dc.rightsDefault Licence-
dc.subjectAnti-HIV Agents/economics/*therapeutic useen
dc.subjectAntiretroviral Therapy, Highly Active/economicsen
dc.subjectDeveloping Countriesen
dc.subject*Hiven
dc.subjectHIV Infections/*drug therapy/economicsen
dc.subject*Health Resourcesen
dc.subjectHumansen
dc.subjectResearch/economics/*methodsen
dc.titleSuitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agendaen
heal.abstractThe delivery of antiretroviral therapy in the developing world requires guidelines for the appropriate monitoring of therapy, including monitoring for treatment effectiveness and treatment failure, drug toxicities, adherence to therapy, and the emergence of resistant organisms. Guidelines developed in wealthy industrialized countries, which rely heavily on laboratory tests often unavailable in the developing world, may not be feasible or appropriate for resource-limited settings. Even if the standard of care routinely delivered in industrialized settings cannot be replicated, antiretroviral treatment programs with less-intense monitoring have the potential to reduce morbidity and mortality from human immunodeficiency virus. Research to identify monitoring strategies that provide the greatest benefit to those living with human immunodeficiency virus in resource-limited settings and that use the available technologies and resources needs to be conducted within a conceptual and ethical framework that takes into account differences between rich and poor countries.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1086/375368-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/12822128-
heal.identifier.secondaryhttp://cid.oxfordjournals.org/content/37/Supplement_1/S13.full.pdf-
heal.journalNameClin Infect Disen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2003-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: